Equities

CSMED

DK0061668225

End-of-day quote NORDIC GROWTH MARKET Other stock markets 03:30:00 28/05/2024 am IST			5-day change	1st Jan Change
5.226 ^DKK	-17.44%		-12.99%	+11.60%

23/05	Transcript : CS Medica A/S, H1 2024 Earnings Call, May 23, 2024
17/05	CS Medica A/S Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	CI

CS MEDICA A/S Provides Revenue Guidance for 2023/2024

May 02, 2022 at 11:04 pm IST

CS MEDICA A/S provided revenue guidance for 2023/2024. The revenue goal of DKK 150 million is sought to be accomplished in the financial year 2023/2024.

Latest news about CS MEDICA A/S

Transcript : CS Medica A/S, H1 2024 Earnings Call, May 23, 2024	23/05
CS Medica A/S Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	17/05	CI
CS Medica A/S Enters New Partnership with OTC Company Holding A Strong Position in the Chronic Pain Segment in Germany	30/04	CI
CS Medica A/S Advances Global Reach with 180° Drug Store Alliance, Powered by Pull Market Strategy	22/04	CI
Transcript : CS Medica A/S, Q4 2023 Earnings Call, Apr 12, 2024	12/04
CS Medica A/S Breaks Through Asian Market Barrier with Approval of Protective Nasal Gel in Malaysia	04/04	CI
Transcript : CS Medica A/S, 2023 Earnings Call, Feb 21, 2024	21/02
CS MEDICA A/S Partners with New Distributor to Launch CANNASEN into Jordan	20/02	CI
CS Medica Obtains Danish Patent for Wound Healing Gel	02/02	MT
CS Medica Set to Launch Pain Patch, Cosmetic Products in Australia	26/01	MT
CS Medica A/S Announces FDA Authorization for Commercialization for Eight Products in the U.S. Market	27/12	CI
Transcript : CS Medica A/S, Q4 2023 Earnings Call, Dec 05, 2023	05/12
CS Medica A/S Announces Financial Year Change	22/11	CI
CS Medica A/S Reports Earnings Results for the Fourth Quarter Ended September 30, 2023	22/11	CI
CS Medica A/S Reports Earnings Results for the Full Year Ended September 30, 2023	22/11	CI
CS Medica's Nasal Protect Gel Secures Second Patent in Denmark	31/23/31	MT
Cs Medica A/S Announces Indian State's Fda Approval for Two Cosmetic Products	12/23/12	CI
Danske Bank Extends DKK 1.2 Million Credit Line to CS MEDICA	10/23/10	CI
CS Medica A/S Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	14/23/14	CI
CS Medica Secures Denmark Patent for Nasal Spray	30/23/30	MT
Transcript : CS Medica A/S, Q3 2023 Earnings Call, Aug 08, 2023	08/23/08
CS MEDICA A/S Announces Establishment of CANNORDIC India Pvt. Ltd. to Expand Presence in India	14/23/14	CI
CS Medica A/S Signs New Own-Label Agreement on Pain Patch	21/23/21	CI
CS Medica Signs Deal for Future Compliance for CE-marked Medical Devices with CBD in EU	16/23/16	MT
CS MEDICA A/S Secures Future Compliance with New Medical Device Regulation Through Signed Contract with Notify Body	15/23/15	CI

Chart CS MEDICA A/S

Duration

Period

More charts

Company Profile

Sector

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar